Korea's national tobacco company; also sells ginseng health products (Korea Ginseng Corp) and exports cigarettes globally.
Korea's national tobacco company; also sells ginseng health products (Korea Ginseng Corp) and exports cigarettes globally.
Sells cigarettes through wholesalers and convenience stores to habit-bound domestic smokers, while exports go to markets such as the Middle East and Central Asia. The ginseng unit sells under the Cheong Kwan Jang brand as a non-tobacco line. The state monopoly ended in 2002 when the company was privatized.
In one line: Korea's Altria, plus a ginseng/health-supplement arm.
Moat: narrow (brand, distribution, regulatory licence). Dominant domestic distribution and brand; former state tobacco monopoly heritage.
Headquarters: Daejeon, South Korea · Founded: 1899 · Employees: 4,331
Size KT&G (033780.KS) is a South Korea Consumer Staples company (Tobacco) with a market value of $14.5B, the 27th largest of 483 South Korea companies the cockpit tracks. Shares closed at ₩182,000 on 18 Nov 2026.
Performance Over six months the shares fell 3.7%, against -4.4% for the median peer and -37.2% for the South Korea market (cap-weighted) — 7th highest of 14 in its peer set.
Growth Revenue grew 9.4% over the last twelve months (peer median +2.4%); the operating margin is 22.1% (peer median 19.3%).
Valuation It trades at 17.6× forward earnings against a peer median of 15.6× (6th most expensive of 13).
Price implies For today's price to make sense, revenue must grow about -6% a year for seven years (Req g). Recent delivered growth is +5%, so the hurdle is -11 pp: the price already allows for a slowdown.
Capital Return on invested capital runs 6.3 points above its cost of capital (5.5% WACC).
Next results Next results expected around 21 Jan 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | ₩7.02T | ₩6.58T | ₩5.91T | ₩5.86T | ₩5.85T |
| Revenue growth | — | +11% | +1% | 0% | — |
| Gross profit | ₩3.32T | ₩3.05T | ₩2.82T | ₩2.73T | ₩2.96T |
| EBITDA | ₩1.86T | ₩1.63T | ₩1.44T | ₩1.40T | ₩1.49T |
| Net income | ₩1.12T | ₩1.09T | ₩1.17T | ₩903B | ₩1.02T |
| Free cash flow | ₩849B | -₩17.0B | ₩112B | ₩850B | ₩753B |
| Capital expenditure | ₩503B | ₩680B | ₩800B | ₩515B | ₩286B |
| Total debt | ₩2.01T | ₩1.84T | ₩1.52T | ₩605B | ₩193B |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
| Company | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g |
|---|---|---|---|---|---|---|
| KT&G 033780.KS | $14.5B | -4% | +9% | 22% | 17.6× | -5.9% |
| Philip Morris International PM | $300B | +3% | +8% | 38% | 22.1× | -0.9% |
| British American Tobacco p.l.c BATS.L | $126B | -9% | +1% | 38% | 12.4× | 3.8% |
| Japan Tobacco 2914.T | $64.4B | -3% | +13% | 25% | 15.6× | -6.9% |
| Altria MO | $127B | +6% | +2% | 75% | 12.9× | -10.7% |
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | 033780.KS | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | -6.2% | -1.9% | 4th lowest of 14 |
| 6-month return | -3.7% | -4.4% | 7th highest of 14 |
| Distance from 52-week high | -9.4% | -28.0% | 2nd highest of 14 |
| Revenue growth (TTM) | +9.4% | +2.4% | 4th highest of 14 |
| Operating margin | 22.1% | 19.3% | 6th highest of 14 |
| Forward P/E | 17.6× | 15.6× | 6th most expensive of 13 |
| Growth the price implies (Req g, 7 yrs) | -5.9% | 3.6% | 6th least demanding of 14 |
| Growth delivered (Del g) | +5.4% | +5.7% | 7th lowest of 14 |
| Hurdle (Req g minus delivered) | -11.3 pp | -8.0 pp | 5th least demanding of 14 |
| ROIC minus cost of capital | +6.3 pp | +8.4 pp | 7th lowest of 14 |
| EV / EBITDA | 10.5× | 10.3× | 7th most expensive of 14 |
| Net debt / EBITDA | 0.1× | 0.7× | 6th least indebted of 14 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| KT&G 033780.KS | South Korea | $14.5B | -4% | +9% | 22% | 17.6× | -5.9% | +5.4% |
| Imperial Brands IMB.L | United Kingdom | $27.9B | +2% | +4% | 17% | 7.9× | -8.8% | +3.5% |
| Smoore International 6969.HK | Hong Kong | $6.01B | -24% | +25% | 7% | 29.3× | 26.8% | +6.6% |
| ITC ITC.NS | India | $39.7B | -4% | -2% | 30% | 21.2× | 14.2% | +9.8% |
| Japan Tobacco 2914.T | Japan | $64.4B | -3% | +13% | 25% | 15.6× | -6.9% | +10.6% |
| Godfrey Phillips India GODFRYPHLP.NS | India | $2.94B | -25% | +4% | 19% | 15.7× | 26.7% | +20.6% |
| China Tobacco International (HK) 6055.HK | Hong Kong | $2.20B | +2% | -20% | 10% | 18.9× | 3.6% | +33.1% |
| British American Tobacco p.l.c BATS.L | United Kingdom | $126B | -9% | +1% | 38% | 12.4× | 3.8% | -0.1% |
| Altria MO | United States | $127B | +6% | +2% | 75% | 12.9× | -10.7% | -0.7% |
| Scandinavian Tobacco Group A/S STG.CO | Denmark | $972M | +20% | -2% | 14% | 8.0× | -10.2% | +2.4% |
| Turning Point Brands TPB | United States | $945M | -48% | +24% | 13% | 29.6× | 9.7% | +2.7% |
| Philip Morris International PM | United States | $300B | +3% | +8% | 38% | 22.1× | -0.9% | +7.2% |
| Miquel y Costas & Miquel MCM.MC | Spain | $427M | -28% | -4% | 15% | n/a | -7.4% | +2.7% |
| VST Industries VSTIND.NS | India | $353M | -24% | -2% | 22% | 8.7× | 9.6% | +5.7% |